Immune checkpoint inhibition in patients with brain metastases
Editorial
Immune checkpoint inhibition in patients with brain metastases
Tanner Johanns, Saiama N. Waqar, Daniel Morgensztern
Abstract
Metastatic brain tumors are the most common type of central nervous system (CNS) malignancies in adults, outnumbering primary CNS tumors by approximately 10:1 (1).
